4//SEC Filing
Tubridy Karen L 4
Accession 0000899243-18-030797
CIK 0001517022other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 8:18 AM ET
Size
8.1 KB
Accession
0000899243-18-030797
Insider Transaction Report
Form 4
Tubridy Karen L
SVP, Chief Development Officer
Transactions
- Tax Payment
Common Stock
2018-12-12$8.94/sh−11,928$106,636→ 30,229 total
Footnotes (1)
- [F1]Includes 639 shares acquired under the Akebia Therapeutics, Inc. stock purchase plan on June 29, 2018.
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001589888
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 8:18 AM ET
- Size
- 8.1 KB